The Latest
Roche’s Collaborator MediLink Announces Phase III Data For Tam-Peli Showing Significantly Improved Overall Survival In Chinese Patient Population With Relapsed Small-cell Lung Cancer
MediLink, Roche collaborator, announces phase III trial results showing improved survival for Tam-Peli in Chinese relapsed small-cell lung cancer patients.